Tradewinds Capital Management’s Twist Bioscience TWST Stock Holding History

Tradewinds Capital Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$2.03K	–	526
2023 Q3	$2.03K	Hold	100	–	–	﹤0.01%	340
2023 Q2	$2.05K	Hold	100	–	–	﹤0.01%	328
2023 Q1	$1.51K	Hold	100	–	–	﹤0.01%	354
2022 Q4	$2.38K	Hold	100	–	–	﹤0.01%	353
2022 Q3	$4K	Hold	100	–	–	﹤0.01%	290
2022 Q2	$3K	Hold	100	–	–	﹤0.01%	326
2022 Q1	$5K	Hold	100	–	–	﹤0.01%	578
2021 Q4	$8K	Hold	100	–	–	﹤0.01%	528
2021 Q3	$11K	Hold	100	–	–	﹤0.01%	457
2021 Q2	$13K	Hold	100	–	–	﹤0.01%	439
2021 Q1	$12K	Hold	100	–	–	﹤0.01%	427
2020 Q4	$14K	Hold	100	–	–	﹤0.01%	383
2020 Q3	$8K	Buy	+100	New	+$6.23K	﹤0.01%	431
2020 Q2	–	Sell	-156	Closed	-$5K	–	721
2020 Q1	$5K	Buy	+156	New	+$4.19K	﹤0.01%	460

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tradewinds Capital Management's TWST Position: Q4 2023 in Review

Tradewinds Capital Management sold out of Twist Bioscience (TWST) in Q4 2023, closing a stake of 100 shares — an estimated $2.03K sold.

Tradewinds Capital Management first reported a position in TWST in Q1 2020 and held it in 14 quarters. The position peaked at $14K in Q4 2020. 218 funds tracked by Wall St. Rank hold TWST as of Q4 2023.

Tradewinds Capital Management reported no remaining Twist Bioscience position as of Q4 2023 after selling out during the quarter.
Tradewinds Capital Management sold 100 Twist Bioscience shares in Q4 2023, an estimated $2.03K.
Tradewinds Capital Management first reported a position in Twist Bioscience in Q1 2020 and held it in 14 quarters.
Tradewinds Capital Management's Twist Bioscience position peaked at $14K in Q4 2020.
218 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2023.

Based on Tradewinds Capital Management's 13F filing for Q4 2023, filed 1 Feb 2024.